Search

everythinglearnresearchcommunity

for

Search:↓

JAK inhibitors are effective and generally safe for treating alopecia areata, but monitoring for side effects is important.

HOTTIP and miR-10b may be targeted to improve glioma treatment by reducing resistance to chemotherapy.

The Bethesda system is effective for identifying thyroid cancer but has low sensitivity.

Finasteride use may increase the risk of male breast cancer.

Chemotherapy with carboplatin-paclitaxel causes hair loss in all patients.

The botanical treatment for hair loss shows promise, especially for children.

Two new compounds can block androgen receptor activity in different ways and may lead to new treatments for androgen-related diseases.

Researchers created specific antibodies that detect a protein important in development and various conditions, and can be used for research and diagnosis.

Rat hair follicle stem cells can be used to improve blood vessel growth in engineered skin.

2h-ICPR can help screen for insulin antibodies in type 2 diabetes patients.

Baricitinib effectively improved both atopic dermatitis and alopecia areata symptoms in a patient.

Vitamin D receptor gene changes don't affect alopecia areata risk.

Cosmerna ARI effectively reduces hair loss and increases hair density in Europeans with androgenetic alopecia.

Anifrolumab significantly improved skin lesions and hair regrowth in severe discoid lupus.

New method measures minoxidil concentration faster, more accurately, and automatically.

Brepocitinib 30mg is most effective for moderate-to-severe alopecia areata, but ritlecitinib 50mg may offer a better balance of safety and effectiveness.

Scientists made a sensor that can detect a specific type of RNA related to androgen receptors quickly and accurately.

Dutasteride reduces hospitalization and prostate cancer risk compared to finasteride, potentially offsetting its higher cost.

Baricitinib is effective and safe for treating severe alopecia areata with ongoing use.

Baricitinib effectively reduces hair loss in severe alopecia areata with mild side effects.

Deuruxolitinib effectively regrows hair in adults with alopecia areata and is well tolerated.

A specific genetic marker is linked to male pattern baldness in Han Chinese men.

The SAAD-41 scale effectively measures the psychosocial impact of alopecia areata.

Two siblings with a genetic mutation had a form of rickets that doesn't respond to vitamin D.

Alopecia areata patients show increased inflammation and OX40 activation, suggesting a new treatment target.

PUVA treatment is effective and safe for alopecia areata.

Most pediatric cancer patients at Muhimbili National Hospital experienced adverse drug reactions during chemotherapy, highlighting the need for careful monitoring.

Lupus severely affects daily life, work, and mental health, with many experiencing frequent flares and medication side-effects.

The androgen receptor's shape-changing ability helps it function but can lead to cancer treatment resistance.